Figure 4.
Figure 4. Differential regulation of S1P receptor expression on activation. T cells were either left intact (nonactivated) or were activated with PMA plus ionomycin or anti-CD3 plus anti-CD28 for 3 days. These cells were then labeled with antibodies to S1P1, S1P2, S1P3, S1P4, or S1P5. Background controls in the presence of rabbit IgG (for S1P1, S1P4, and S1P5) or mouse IgG (for S1P2 and S1P3) and FITC-conjugated secondary antibodies are shown in black. Numbers indicate the percentage of positive cells in one experiment. In 3 to 4 experiments performed, the percentage of positive cells for S1P1, S1P2, S1P3, S1P4, and S1P5 ranges between 83% and 98%, less than 0.1%, 1% and 15%, 25% and 50%, and 5% and 25% for nonactivated cells; 52% to 83%, less than 0.1%, 15% and 40%, 20% and 30%, and 23% and 41% for PMA plus ionomycin-treated cells; and 5% and 70%, less than 0.1%, 15% and 30%, 20% and 25%, and 12% and 26% for anti-CD3 plus anti-CD28 activated cells, respectively. White histograms represent the binding of the specific antibodies.

Differential regulation of S1P receptor expression on activation. T cells were either left intact (nonactivated) or were activated with PMA plus ionomycin or anti-CD3 plus anti-CD28 for 3 days. These cells were then labeled with antibodies to S1P1, S1P2, S1P3, S1P4, or S1P5. Background controls in the presence of rabbit IgG (for S1P1, S1P4, and S1P5) or mouse IgG (for S1P2 and S1P3) and FITC-conjugated secondary antibodies are shown in black. Numbers indicate the percentage of positive cells in one experiment. In 3 to 4 experiments performed, the percentage of positive cells for S1P1, S1P2, S1P3, S1P4, and S1P5 ranges between 83% and 98%, less than 0.1%, 1% and 15%, 25% and 50%, and 5% and 25% for nonactivated cells; 52% to 83%, less than 0.1%, 15% and 40%, 20% and 30%, and 23% and 41% for PMA plus ionomycin-treated cells; and 5% and 70%, less than 0.1%, 15% and 30%, 20% and 25%, and 12% and 26% for anti-CD3 plus anti-CD28 activated cells, respectively. White histograms represent the binding of the specific antibodies.

Close Modal

or Create an Account

Close Modal
Close Modal